KIF23 and breast cancer: Zou and colleagues verified that overexpression of KIF23 was significantly associated with prognosis in ER-positive breast cancer patients and that knockdown of KIF23 inhibited tamoxifen-sensitive and resistant breast cancer cell proliferation and induced apoptosis 13.